Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Hormonal Contraceptive market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Hormonal Contraceptive market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Hormonal Contraceptive market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Hormonal Contraceptive products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Hormonal Contraceptive products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Hormonal Contraceptive market.
To learn more about this report
Increasing research and development spending on Hormonal Contraceptive development has been the leading industry trend of Hormonal Contraceptive market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Transdermal Patches |
| By Application Outlook | Hospitals, Household, Clinics, Other |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Ansell Limited, Bayer AG, Church and Dwight Co, Johnson and Johnson, Mayer Laboratories, Merck and Co, Mylan N.V., Pfizer, Teva Pharmaceutical Industries, The Female Health Company, Organon International, Afaxys |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Hormonal Contraceptive Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Hormonal Contraceptive Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Hormonal Contraceptive Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Hormonal Contraceptive Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Oral Contraceptive Pills
4.2.2 Injectable Birth Control
4.2.3 Emergency Contraceptive Pills
4.2.4 Vaginal Rings
4.2.5 Transdermal Patches
4.4 Type Comparison Matrix
4.5 Global Hormonal Contraceptive Market Attractiveness, By Type
5 Global Hormonal Contraceptive Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Hormonal Contraceptive Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Hospitals
5.3.2 Household
5.3.3 Clinics
5.3.4 Other
5.4 Application Comparison Matrix
5.5 Global Hormonal Contraceptive Market Attractiveness, by Application
6 Global Hormonal Contraceptive Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Hormonal Contraceptive Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Hormonal Contraceptive Market Attractiveness, by Region
8 North America Hormonal Contraceptive Market Analysis and Forecast
8.1 Key Findings
8.2 North America Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Oral Contraceptive Pills
8.2.2 Injectable Birth Control
8.2.3 Emergency Contraceptive Pills
8.2.4 Vaginal Rings
8.2.5 Transdermal Patches
8.3 North America Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Hospitals
8.3.2 Household
8.3.3 Clinics
8.3.4 Other
8.4 North America Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Hormonal Contraceptive Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Hormonal Contraceptive Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Oral Contraceptive Pills
9.2.2 Injectable Birth Control
9.2.3 Emergency Contraceptive Pills
9.2.4 Vaginal Rings
9.2.5 Transdermal Patches
9.3 Europe Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Hospitals
9.3.2 Household
9.3.3 Clinics
9.3.4 Other
9.4 Europe Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Hormonal Contraceptive Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Hormonal Contraceptive Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Oral Contraceptive Pills
10.2.2 Injectable Birth Control
10.2.3 Emergency Contraceptive Pills
10.2.4 Vaginal Rings
10.2.5 Transdermal Patches
10.3 Asia Pacific Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Hospitals
10.3.2 Household
10.3.3 Clinics
10.3.4 Other
10.4 Asia Pacific Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Hormonal Contraceptive Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Oral Contraceptive Pills
11.2.2 Injectable Birth Control
11.2.3 Emergency Contraceptive Pills
11.2.4 Vaginal Rings
11.2.5 Transdermal Patches
11.3 Latin America Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Hospitals
11.3.2 Household
11.3.3 Clinics
11.3.4 Other
11.4 Latin America Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Hormonal Contraceptive Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Hormonal Contraceptive Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Oral Contraceptive Pills
12.2.2 Injectable Birth Control
12.2.3 Emergency Contraceptive Pills
12.2.4 Vaginal Rings
12.2.5 Transdermal Patches
12.3 Middle East & Africa (MEA) Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Hospitals
12.3.2 Household
12.3.3 Clinics
12.3.4 Other
12.4 Middle East & Africa (MEA) Hormonal Contraceptive Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Hormonal Contraceptive Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Ansell Limited
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Bayer AG
13.3.3 Church and Dwight Co
13.3.4 Johnson and Johnson
13.3.5 Mayer Laboratories
13.3.6 Merck and Co
13.3.7 Mylan N.V.
13.3.8 Pfizer
13.3.9 Teva Pharmaceutical Industries
13.3.10 The Female Health Company
13.3.11 Organon International
13.3.12 Afaxys
14 Key Takeaways
Choose License Type